Genomma Lab Internacional S.A.B. de C.V

Price Chart

Risk-Adjusted Performance

Also Listed On

Genomma Lab Internacional S.A.B. de C.V (LABB) Price Performance

Genomma Lab Internacional S.A.B. de C.V (LABB) trades on MX in MXN. The company is classified in the Healthcare sector under the Drug Manufacturers - Specialty & Generic industry. The stock currently trades at MXN18.79, down 0.79% from the previous close.

Over the past year, LABB has traded between a low of MXN16.02 and a high of MXN24.03. The stock has lost 13.4% over this period. It is currently 21.8% below its 52-week high.

Genomma Lab Internacional S.A.B. de C.V has a market capitalization of $17.54B, with a price-to-earnings ratio of 10.92.

About Genomma Lab Internacional S.A.B. de C.V

Genomma Lab Internacional, S.A.B. de C.V., together with its subsidiaries, provides pharmaceutical and personal care products primarily in Mexico and internationally. It develops, sells, and markets a range of branded products in the categories of anti-acne products, self-diagnosis, antibacterial, cream to improve the texture of scarred skin, shampoos, dandruff shampoos, soaps, razors, products to prevent hair loss, ointment for muscle pain, anti-fungal treatments for the relief of colitis, products to counter stress levels, anti-wrinkles, antacids, anti-ulcers, anti-flu, protection and improvement products, treatments against hemorrhoids, against varicose veins, osteoarthritis, ophthalmic medications, infant nutrition, and others. Genomma Lab Internacional, S.A.B. de C.V. was incorporated in 1996 and is based in Mexico City, Mexico.